Aevi Genomic Medicine, Inc.
(NASDAQ : GNMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.09%53.040.9%$1379.63m
JNJJohnson & Johnson 1.37%179.400.7%$1371.06m
BMYBristol-Myers Squibb Co. 1.04%76.981.0%$1209.69m
MRKMerck & Co., Inc. 0.64%94.150.7%$1146.96m
ABBVAbbVie, Inc. -1.07%149.401.9%$1125.99m
LLYEli Lilly & Co. 1.43%303.131.1%$904.99m
AZNAstraZeneca Plc 0.65%66.641.0%$521.01m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.09%143.580.0%$463.50m
VERUVeru, Inc. -1.46%13.190.0%$314.13m
NVSNovartis AG 1.44%90.700.2%$254.79m
GSKGlaxoSmithKline Plc 0.67%44.820.2%$244.80m
HZNPHorizon Therapeutics Plc -2.16%88.405.4%$196.07m
NVONovo Nordisk A/S 0.22%107.990.1%$191.15m
SGENSeagen Inc. 0.29%140.055.7%$182.29m
VTRSViatris, Inc. -1.53%11.620.0%$163.59m

Company Profile

Aevi Genomic Medicine focuses on translating genetic discoveries into novel therapies. It is dedicated to unlocking the potential of genomic medicine to translate genetic discoveries into novel therapies. Driven by a commitment to patients with pediatric onset life-altering diseases, the company's research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics at The Children's Hospital of Philadelphia.